Peter Hotez: What You Need To Know

peter hotezPeter Hotez, M.D. is an internationally-recognized virologist, clinician and investigator, specializing in neglected tropical diseases control and vaccine development.

He is the founding dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, where he teaches in the Departments of Pediatrics and Molecular Virology & Microbiology and is in charge of the recently created Section of Pediatric Tropical Medicine. He also holds the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics.

Hotez’s devotion to vaccine development has led him to serve as the current president of the Sabin Vaccine Institute, as well as director of the Texas Children’s Hospital Center for Vaccine Development and as a Baker Institute Fellow in Disease and Poverty at Rice University.

Read the latest articles about Peter Hotez’s work at the Sabin Vaccine Institute:

peter hotez experimentingPeter Hotez’s academic background and publications

After obtaining an undergraduate degree in molecular biophysics from Yale University in 1980, Peter Hotez received his Ph.D.  in biochemical parasitology from Rockefeller University in 1986. One year later, Hotez earned his M.D. from Weill Cornell Medical College, followed by pediatric residency training at Massachusetts General Hospital between 1987 and 1989. He then returned to Yale for postdoctoral fellowship training in infectious diseases and molecular parasitology, from 1989 to 1991.

There are more than 300 original papers authored by Peter Hotez, some of them published as lead pieces in the New England Journal of Medicine, Lancet, Science, and Scientific American to name just a few, and is a regular contributor at the Huffington Post. He has also made his mark in medical journalism, having contributed  over 36 op-ed articles to the New York Times, LA Times, and the Washington Post. He has also written  over 60 textbook chapters.

Of the ten authored and published books by Peter Hotez, “Forgotten People, Forgotten Diseases” (ASM Press, 2008) is his most acclaimed release, which outlines the full scope of “Neglected Tropical Diseases,” the widespread socio-economic impact these diseases have on keeping developing countries from growing, and the reluctance of developed nations to assist in stamping out NTDs that, with the proper funding and resources, are treatable and curable.

peter hotez awardHonors & Awards

As a well-known investigator and highly respected by his peers, Peter Hotez has received a considerable amount of prizes and awards, including the The Abraham Horwitz Award, awarded by the Pan American Health and Education Foundation and Pan American Health Organization to Peter Hotez, in 2011, for excellence in leadership in Inter-American public health guidelines.

Among other honors, Peter Hotez was presented with the The Leverhulme Medal from the Liverpool School of Tropical Medicine and the The Bailey K. Ashford Medal, offered to him in 2003 by the American Society of Tropical Medicine and Hygiene, for distinguished work in tropical medicine. Peter Hotez outstanding contributions to parasitology studies were distinguished in 1999 with the Ward Medal from the American Society of Parasitologists.

The above-mentioned awards not only speak to Dr. Hotez’s expertise and prowess in the laboratory, but also to his work as an advocate for the developing world. He regularly lobbies U.S. Congress and other governmental bodies throughout the world to increase funding and resources to projects designed to stamp out many of the NTDs that continue to plague countries in Central and South America, Africa, and Asia.

Read the latest news about Peter Hotez’ work:

Ongoing investigations and projects led by Peter Hotez

Peter Hotez presently works as the main investigator for research grants from the Bill & Melinda Gates Foundation, the Dutch government, and the National Institutes of Health and is co-principal investigator for a research grant from the Carlos Slim Health Institute. He is also in charge of a unique partnership for developing new vaccines for hookworm infection, schistosomiasis, and Chagas, deseases that get hundreds of millions of children and adults all over the world.

Scroll To Top